chronic / drug therapy*

Explore academic connections and research related to this keyword

371
Views
22
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Telaprevir for previously untreated chronic hepatitis C virus infection
Jacobson IM;McHutchison JG;Dusheiko G;Di Bisceglie AM;Reddy KR;Bzowej NH;Marcellin P;Muir AJ;Ferenci...
2011 The New England journal of medicine 649 views
2
Boceprevir for untreated chronic HCV genotype 1 infection
Poordad F;McCone J;Bacon BR;Bruno S;Manns MP;Sulkowski MS;Jacobson IM;Reddy KR;Goodman ZD;Boparai N;...
2011 The New England journal of medicine 509 views
3
Hepatitis C Virus-Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens
Stepanova M;Thompson A;Doyle J;Younossi I;de Avila L;Younossi ZM;;
2018 The Journal of infectious diseases 408 views
4
Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct-acting antivirals
Schütz A;Moser S;Schwanke C;Schubert R;Luhn J;Gutic E;Lang T;Schleicher M;Haltmayer H;Gschwantler M;...
2018 journal of viral hepatitis 392 views
5
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis
Kwo PY;Poordad F;Asatryan A;Wang S;Wyles DL;Hassanein T;Felizarta F;Sulkowski MS;Gane E;Maliakkal B;...
2017 journal of hepatology 471 views
6
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial
Dore GJ;Altice F;Litwin AH;Dalgard O;Gane EJ;Shibolet O;Luetkemeyer A;Nahass R;Peng CY;Conway B;Greb...
2016 annals of internal medicine 479 views
7
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
Jacobson IM;Lawitz E;Gane EJ;Willems BE;Ruane PJ;Nahass RG;Borgia SM;Shafran SD;Workowski KA;Pearlma...
2017 gastroenterology 397 views
8
Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial
Wyles D;Poordad F;Wang S;Alric L;Felizarta F;Kwo PY;Maliakkal B;Agarwal K;Hassanein T;Weilert F;Lee...
2018 Hepatology (Baltimore, Md.) 370 views
9
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis
Asselah T;Kowdley KV;Zadeikis N;Wang S;Hassanein T;Horsmans Y;Colombo M;Calinas F;Aguilar H;de Ledin...
2018 clinical gastroenterology and hepatology : the off... 417 views
10
An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens
Younossi ZM;Stepanova M;Henry L;Nader F;Hunt S;;
2016 the american journal of gastroenterology 373 views
11
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis
Asselah T;Bourgeois S;Pianko S;Zeuzem S;Sulkowski M;Foster GR;Han L;McNally J;Osinusi A;Brainard DM;...
2018 liver international : official journal of the inte... 357 views
12
Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies
Hezode C;Reau N;Svarovskaia ES;Doehle BP;Shanmugam R;Dvory-Sobol H;Hedskog C;McNally J;Osinusi A;Bra...
2018 journal of hepatology 394 views
13
Regression of Hodgkin lymphoma in response to antiviral therapy for hepatitis C virus infection
Takahashi K;Nishida N;Kawabata H;Haga H;Chiba T;;
2012 internal medicine (tokyo, japan) 374 views
14
Chronic hepatitis B
Lok AS;McMahon BJ;;
2007 Hepatology (Baltimore, Md.) 504 views
15
Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?
Christensen S;Buggisch P;Mauss S;Böker KHW;Schott E;Klinker H;Zimmermann T;Weber B;Reimer J;Serfert...
2018 addiction (abingdon, england) 342 views
16
Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C
Younossi ZM;Stepanova M;Henry L;Gane E;Jacobson IM;Lawitz E;Nelson D;Gerber L;Nader F;Hunt S;;
2014 clinical gastroenterology and hepatology : the off... 351 views
17
Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents
Sise ME;Bloom AK;Wisocky J;Lin MV;Gustafson JL;Lundquist AL;Steele D;Thiim M;Williams WW;Hashemi N;K...
2016 Hepatology (Baltimore, Md.) 382 views
18
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial
Lawitz E;Gane E;Pearlman B;Tam E;Ghesquiere W;Guyader D;Alric L;Bronowicki JP;Lester L;Sievert W;Gha...
2015 Lancet (London, England) 359 views
19
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
Foster GR;Afdhal N;Roberts SK;Bräu N;Gane EJ;Pianko S;Lawitz E;Thompson A;Shiffman ML;Cooper C;Towne...
2015 The New England journal of medicine 425 views
20
Sofosbuvir for previously untreated chronic hepatitis C infection
Lawitz E;Mangia A;Wyles D;Rodriguez-Torres M;Hassanein T;Gordon SC;Schultz M;Davis MN;Kayali Z;Reddy...
2013 The New England journal of medicine 440 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

hepatitis c National Center for Biotechnology Information NCBI NLM MEDLINE RNA humans pubmed abstract nih national institutes of health national library of medicine logistic models research support non-u.s. gov't adult female male aged middle aged young adult